הרבעון המשמעותי ביותר עד כה עבור רובוטיקה הומנואידית ---
90 הימים הקרובים — מיוני ועד תחילת ספטמבר 2026 — מהווים נקודת מפנה אמיתית עבור תעשיית הרובוטיקה ההומנואידית. בתוך חלון זה, צפויים להסגר סבבי מימון מרובים, לפחות שתי הקמות ייצור ייבחנו מול שרשראות אספקה אמיתיות, ענקית אוטומציה תעשייתית ותיקה נכנסת למרחב ההומנואידי, ויוזמת השקעה בתחום הבריאות שנתמכת על ידי Toyota עולה לאוויר. עבור כל מי שעוקב אחרי הזרמת ההון ואילו פלטפורמות יהיו חשובות ב-2027, הסימנים שמגיעים לפני יום העבודה יהיו מכריעים. הנה מה לעקוב אחריו, מתי לעקוב אחריו, ומה זה אומר. ---
הצמד של Figure AI: שלוש הכרזות אפשריות ב-13 ימים ---
הצמד האירועים הדחוס ביותר בלוח השנה שייך ל-Figure AI, שיש לה שני תאריכים מדוברים — 8 ביוני ו-20 ביוני — המקושרים להכרזות שונות אך מקושרות: סגירת גיוס Series C, השקת ייצור סדרת Figure 02, וחשיפת לוח זמנים לפלטפורמת H-01. אם אפילו שניים משלושת אלה יתממשו בהתאמה ללוח הזמנים, Figure AI תבצע את הסלולה הנרטיבית המהירה ביותר בהיסטוריה הקצרה של המגזר. --- Figure AI Figure AIלמה זה חשוב מעבר למספרי הכותרת? Figure 03 כבר מייצרת ציון סנטימנט של 8.2/10 על פני עשרה אזכורים מוסדרים השבוע, כאשר אנליסטים מצטטים שיפורים מהירים בביצוע משימות פיזיות והרחבת הפעלות בייצור וקמעונאות. אך Figure 03 עדיין רשומה כמוצר בפיתוח עם מחיר יעד מתחת ל-20,000$ — פער בין הבטחה למוצר שסגירת Series C והשקת ייצור Figure 02 מאומתת יתחילו לגשר עליו באופן משכנע. עקוב אחר פרטי הרחבת המפעל במיוחד: אם Figure AI מכריזה על מתקן ייצור ייעודי במקום הסכם ייצור בחוזה, זה מאותת על מעבר אסטרטגי לאינטגרציה אנכית שיפעיל לחץ על מתחרים שעדיין מסתמכים על הרכבה של צד שלישי. --- Tesla, 20 ביוני: ציון דרך בייצור — אמיתי או שאיפתי? --- and ו- גם מדובר על השקת ייצור Tesla Optimus ב-20 ביוני, עם יעד של 10,000 יחידות. הקשר הוא חיוני כאן. נכון למרץ 2026, Tesla אישרה ב-AWE Shanghai שייצור המוני יכול להתחיל עד סוף 2026, כאשר Fremont מכוונת לעד מיליון יחידות בשנה בהקמה מלאה — וייצור Optimus 3 מתחיל בקיץ 2026. ציון דרך של 10,000 יחידות עד 20 ביוני ייצג את המספר הקשיח והניתן לאימות הראשון המקושר למפת הדרכים הזו. --- סנטימנט המשקיעים סביב
בתוך הרובוט הויראלי IRON שכולם חשבו שהוא אנושי | מה העתיד - CNET
Why does this matter beyond the headline numbers? Figure 03 is already generating a sentiment score of 8.2/10 across ten tracked mentions this week, with analysts citing rapid physical task execution improvements and expanding manufacturing and retail deployments. But Figure 03 remains listed as not available with a target price below $20,000 — a gap between promise and product that a Series C close and a confirmed Figure 02 production launch would begin to close credibly. Watch the factory expansion detail specifically: if Figure AI announces a dedicated production facility rather than a contract manufacturing arrangement, that signals a strategic shift toward vertical integration that would put pressure on competitors still reliant on third-party assembly.
Tesla’s June 20 Production Milestone: Real or Aspirational?
Also rumored for גם מדובר על השקת ייצור Tesla Optimus ב-20 ביוני, עם יעד של 10,000 יחידות. הקשר הוא חיוני כאן. נכון למרץ 2026, Tesla אישרה ב-AWE Shanghai שייצור המוני יכול להתחיל עד סוף 2026, כאשר Fremont מכוונת לעד מיליון יחידות בשנה בהקמה מלאה — וייצור Optimus 3 מתחיל בקיץ 2026. ציון דרך של 10,000 יחידות עד 20 ביוני ייצג את המספר הקשיח והניתן לאימות הראשון המקושר למפת הדרכים הזו. --- is a Tesla Optimus production ramp-up announcement targeting 10,000 units. Context is essential here. As of March 2026, Tesla confirmed at AWE Shanghai that mass production could begin by end of 2026, with Fremont targeting up to one million units annually at full build-out — and Optimus 3 production starting summer 2026. A 10,000-unit milestone by June 20 would represent the first hard, auditable number attached to that roadmap.
Investor sentiment around Tesla Optimus sits at 7.5/10 this week, tempered specifically by competitive pressure from OpenAI and Nvidia rather than technical doubts. The Gen 2 platform carries a 9 kg per-hand payload and 28 DoF total — respectable mid-tier specs — with a target price of $20,000–$30,000 at scale. The critical analytical question for June 20 is whether Tesla discloses unit economics alongside the volume number. A production ramp without margin disclosure will be read by institutional investors as a signals management exercise, not a commercial milestone. Watch for any mention of external customer allocations beyond internal Gigafactory use.
Unitree G1 North America: The First Confirmed Date on the Calendar
Amid the rumor-heavy cluster above, June 30 stands out as a confirmed event: the commercial release of the Unitree G1 --- in North America. At a base price of $13,500 — the lowest entry point for a full-bipedal humanoid with meaningful payload capability (3 kg per arm, up to 43 DoF in high-configuration builds) — this launch has the potential to reshape the research and light-industrial buyer segments in a way no previous platform has.
Unitree’s week has been complicated. The G1 earned a neutral sentiment score of 5.5/10, buoyed by its America’s Got Talent performance and an NVIDIA research collaboration, but dragged down by a widely-reported incident of a G1 kicking a child during a public demonstration and nascent congressional attention around humanoid robot safety legislation. That regulatory risk is not hypothetical. If Congress advances any restrictive framework before June 30, Unitree’s North American launch could face immediate headwinds regardless of product quality. The IPO approval — confirmed this week for Unitree Robotics — adds a second layer of scrutiny: public company obligations will require Unitree to address safety incidents with more institutional rigor than a private startup. Monitor both the legislative calendar and Unitree’s formal safety response before the June 30 date.
ABB and Toyota: Legacy Players Make Structural Moves
Two July 8 events deserve more attention than they are currently receiving. First, ABB Robotics --- launches a dedicated Humanoid Division — a confirmed date, not a rumor. ABB generated $3.8 billion in robotics revenue in 2025 and operates one of the largest installed bases of industrial automation equipment globally. A humanoid division launch does not mean ABB will ship a competitive platform immediately, but it does mean ABB’s distribution network, service infrastructure, and existing enterprise relationships become available to whatever platform ABB chooses to develop or partner with. This is the most significant legacy-player structural commitment since Hyundai’s Atlas partnership with Boston Dynamics.
On the same date, Toyota’s T-HR3 Healthcare Deployment Initiative goes live — also confirmed. Healthcare is the deployment vertical most analysts agree will absorb humanoid capacity before consumer home use reaches scale, given the combination of acute labor shortages, high tolerance for technology costs, and relatively structured physical environments. Toyota brings not only engineering credibility but clinical partnership networks that startups cannot replicate quickly. The T-HR3 is not a cutting-edge platform by 2026 specifications, but Toyota’s deployment methodology — slow, validated, liability-conscious — could establish the compliance and safety frameworks that the entire sector will eventually need to adopt.
Apptronik Apollo’s European Commercial Launch: Quietly Significant
Rumored for July 1, Apptronik’s Apollo European commercial launch is receiving less coverage than it warrants. Apollo carries a 25 kg payload — the highest confirmed payload figure among commercially positioned platforms — and targets enterprise contracts. The European market presents a distinct regulatory environment, with the EU AI Act creating compliance requirements that do not apply to U.S. deployments. If Apptronik launches in Europe successfully, it will have navigated a compliance framework that will become the de facto global standard for enterprise humanoid deployments. That institutional knowledge has durable competitive value. Apptronik earned an 8.0/10 sentiment score this week on the strength of its factory-work positioning — the European launch, if confirmed, would validate that positioning at market scale.
The Boldest Moves: A Ranked Assessment
- Figure AI (June 8 + June 20): Attempting to close funding, launch production, and reveal a new platform timeline in 13 days is operationally aggressive. Highest upside, highest execution risk.
- ABB Robotics (July 8): A $3.8B revenue industrial automation company entering humanoid robotics with a dedicated division is the boldest structural commitment from a legacy player in the sector’s history.
- Unitree (June 30): Launching a $13,500 humanoid commercially in North America while managing an IPO process and active safety scrutiny simultaneously is a high-wire act with genuine market-creation potential.
- Tesla (June 20): A 10,000-unit production milestone claim will be immediately verifiable. The boldness lies in setting a hard number — a discipline most competitors have carefully avoided.
Risk Factors to Monitor Across All Events
Three structural risks cut across this entire 90-day window. First, congressional humanoid robot legislation — flagged explicitly in Unitree G1 coverage this week — is no longer a theoretical concern. Any committee hearing or bill introduction before June 30 will affect North American launch strategies across multiple vendors. Second, the XPENG IRON situation is a cautionary signal: despite confirmed mass production beginning in January 2026 and 82 active DoF specifications, XPENG earned a 3.5/10 sentiment score this week due to leadership departure, BYD competitive pressure, and internal disputes. Technical capability and commercial execution remain uncorrelated risks. Third, the 1X NEO $20,000 consumer platform — targeting 2026 housework deployment — has not appeared on any confirmed calendar event in this window despite strong 8.5/10 sentiment. Absence from the event calendar at this stage of the year is itself a data point worth tracking.
Your 90-Day Watchlist
- June 8: Figure AI Series C funding close — watch for amount, lead investor, and factory expansion specifics
- June 20: Figure AI Figure 02 production launch + H-01 timeline; Tesla 10,000-unit production milestone — watch for external customer allocation disclosure
- June 30: Unitree G1 North America commercial release — watch pricing, safety documentation, and any regulatory developments preceding launch
- July 1: Apptronik Apollo European commercial launch — watch EU AI Act compliance disclosure
- July 8: ABB Humanoid Division launch structure + Toyota T-HR3 healthcare deployment — watch for partnership announcements and clinical validation frameworks
The humanoid robotics sector has spent three years accumulating proof-of-concept credibility. The next 90 days will determine which companies convert that credibility into durable commercial positions — and which ones discover that announcing a milestone and executing one are different disciplines entirely.
Track every platform mentioned in this analysis — specs, pricing, availability status, and deployment history — in the HumanoidApplications.com Robot Comparison Tool. For the full platform directory, visit our complete robot listings.